CDEK by Data4ThePeople
Sign in Sign up
← All organizations

Navitas Pharma

For profitContributed to NME

Also known as: Ecron Acunova GmbH

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

May 1, 2002

Last known activity

Jun 1, 2016

Acquired by Gilead Sciences on May 29, 2008

Timeline

1980s

  1. Jan 1, 1986

    Navitas Pharma— Founded

2000s

  1. May 29, 2008

    Gilead Sciences— Acquired By

2010s

  1. Feb 13, 2019

    DataCeutics— Acquired

Drugs by trial phase (5 distinct, 4 trials)

Phase 4 (1 own, 0 via acquisition)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (2 own, 0 via acquisition)

Indications

Studied for

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (4)

Details

Founded
Frankfurt, DE Jan 1, 1986
Last known activity
Jun 1, 2016

Notes

--- Pre-folding founded info: 2003-06-01 Laramie WY US https://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=45325411 ---